Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...
In today’s Pharmaceutical Executive Daily, new analysis outlines what it may truly cost to fix the biopharma ecosystem, the ...
Early real-world findings show that Carvykti, a BCMA-directed CAR T-cell therapy, is demonstrating sustained remissions in ...
aTyr Pharma, Inc. (NASDAQ:ATYR), a clinical-stage biotechnology company valued at $286.24 million, is garnering attention from investors and analysts alike as it advances its lead candidate, ...
Critical information sits scattered across disconnected databases. Analysis that should take hours stretches into weeks as ...
During the last three months, 5 analysts shared their evaluations of NewAmsterdam Pharma (NASDAQ:NAMS), revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ...
Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...
Johnson & Johnson and Roche are at the top of S&P Global’s pharmaceutical industry power ratings, which assess the strength of the world’s top 17 drugmakers. To come up with the ranking, S&P ...
The Chosun Ilbo on MSN
Government, Pharma Clash Over Generic Drug Prices
Government, Pharma Clash Over Generic Drug Prices Government cuts generic prices for new drugs; industry fears R&D impact ...
DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/81c5d0/china_pharmaceutic) has announced the addition of the "China ...
Elemental analysis plays a crucial role in the pharmaceutical industry, allowing scientists to understand a material or compound’s elemental composition. It also provides key information on any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback